Log In
Print
BCIQ
Print
Print this Print this
 

ISIS-APOCIIIRx (ISIS 304801)

Also known as: APOC-III antisense inhibitor

  Manage Alerts
Collapse Summary General Information
Company Isis Pharmaceuticals Inc.
DescriptionApolipoprotein C-III (APOCIII; APOC3) antisense inhibitor
Molecular Target Apolipoprotein C-III (APOCIII) (APOC3)
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationHypertriglyceridemia
Indication DetailsTreat hypertriglyceridemia
Regulatory Designation

EU - Orphan Drug (Treat hypertriglyceridemia)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today